Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • What Comes Next for Direct-to-Consumer Genetics?

    Jul 16, 2015, 11:10 AM by Michael Croft
    Bio-IT World | After receiving FDA clearance for a single carrier screening test this February, 23andMe has promised to release a new health product to its customers later this year. But regulations are sure to change the types of genetic tests available on the direct-to-consumer market — and lead some to look for alternative ways to expand public access to useful genomic information.
    Full story
  • Synexus continues expansion across Eastern Europe with three new clinical trial centres

    Jul 15, 2015, 00:00 AM by Michael Croft
    CHORLEY, UNITED KINGDOM - Jul 15, 2015 - Synexus continues to expand across Eastern Europe with three new Dedicated Research Centres in Bulgaria, Poland and Romania, bringing the total to nine centres in Eastern Europe and a total network of 25 across Europe and Africa
    Full story
  • KeyGene and GENALICE report significant mutual benefits of their partnership

    Jul 15, 2015, 00:00 AM by Michael Croft
    HARDERWIJK, NETHERLANDS - Jul 15, 2015 - Today, molecular genetics Ag Biotech company KeyGene and biomedical big data solutions company GENALICE, jointly mark the significant mutual benefits of their first two years of partnerships, running GENALICE MAP in full production as their preferred tool for primary Next-Generation Sequencing (NGS) data analysis
    Full story
  • Qlucore announces 3 year license from Europe's largest biopharmaceutical company

    Jul 15, 2015, 00:00 AM by Michael Croft
    LUND, SWEDEN - Jul 15, 2015 - ~~Qlucore announces 3 year license from Europe's largest biopharmaceutical company
    Software to help Actelion visualize and analyze "big data"
    Qlucore, a world leader in the development of bioinformatics software, has announced a three year license contract with Actelion, one of Europe's leading biopharmaceutical companies
    Full story
  • The Case for Theranos

    Jul 15, 2015, 00:00 AM by Michael Croft
    Forbes | Matthew Herper talks to Elizabeth Holmes and the organizations partnering with her company Theranos, to check out the evidence for her claims to radically reduce the price and burden of blood tests.
    Full story
  • Paul Allen Foundation Grants $7m in Alzheimer's Grants

    Jul 14, 2015, 15:00 PM by Michael Croft
    Bio-IT World News Brief | The Paul G. Allen Family Foundation announced five Allen Distinguished Investigator (ADI) grants to teams of researchers with projects that will open new and innovative avenues of research in Alzheimer’s disease. The projects are funded at a total of $7 million over three years.
    Full story
  • Clinical Conductor CTMS Release Targets Precise, Accurate Research Management

    Jul 14, 2015, 00:00 AM by Michael Croft
    ROCHESTER, NY, UNITED STATES - Jul 14, 2015 - The latest iteration of Clinical Conductor CTMScontinues the proven strategy of providing research organizations with the most in-depth features and functionality available, further distancing the application from others in the industry, which fail to provide the tools necessary for truly complete clinical research management
    Full story
  • Rancho BioSciences and BT to Provide Big Data Cloud Services to Life Sciences Sector

    Jul 14, 2015, 00:00 AM by Michael Croft
    SAN DIEGO, CA, UNITED STATES - Jul 14, 2015 - Rancho BioSciences, the Data Curation Company, today announced that they will work with BT to provide cloud-based data curation services to their joint customers
    Full story
  • IBM Nvidia Energy Department form a supercomputer super team

    Jul 14, 2015, 00:00 AM by Michael Croft
    CNET | Two supercomputing centers of excellence revolve around making sure applications can take advantage of compute horsepower and gathering feedback from developers, engineers and scientists.
    Full story
  • Dr. Lee Hoods scientific wellness startup Arivale raises $36M to improve health through genetics

    Jul 14, 2015, 00:00 AM by Michael Croft
    GeekWire | Lee Hood's new startup, Arivale, raised $36 million yesterday from Arch Venture Partners and Polaris Partners. The company's total funding is now at $40 million.
    Full story
  • XenoTech Announces the Addition of In Vitro Toxicology to Its Extensive Portfolio of Drug Development Services; Appoints Colleen Toole as Principal Scientist of Newly Formed Department

    Jul 14, 2015, 00:00 AM by Michael Croft
    LENEXA, KS, UNITED STATES - Jul 14, 2015 - Contract Research Organization XenoTech, LLC, a division of Sekisui, announces the addition of in vitro toxicology to its global drug development service portfolio
    Full story
  • 21st Century Cures Act Passes House Now Must Navigate Senate

    Jul 10, 2015, 00:00 AM by Michael Croft
    Xconomy | The U.S. House of Representatives took a big step this morning toward major changes in the federal government's relationship to biomedical research, funding and regulation.
    Full story
  • Biogen R and D Chief Doug Williams Leaves to Run New Cancer Startup

    Jul 10, 2015, 00:00 AM by Michael Croft
    Xconomy | Biogen's top research and development executive Doug Williams is leaving the company this month to take the helm at a startup that doesn't yet have a name.
    Full story
  • Juno Revs Armored CAR For Ovarian Cancer Trial

    Jul 10, 2015, 00:00 AM by Michael Croft
    Xconomy | Juno Therapeutics has built remarkable momentum and is about to launch the first trial in humans of engineered T cells.
    Full story
  • Pistoia Alliance Launches Startup Challenge

    Jul 9, 2015, 11:00 AM by Michael Croft
    Bio-IT World | The Pistoia Alliance has launched a business plan contest that will ask startup companies from around the world to develop new ideas to lower the barriers to innovation in life sciences R&D. The Pistoia Alliance President’s Startup Challenge 2015 invites small and medium enterprises to compete for cash prizes and expert mentorship from a senior industry figure drawn from the Pistoia Alliance membership.
    Full story
  • Aridhia announces revolutionary mini-app technology to accelerate clinical application development following RStudio collaboration

    Jul 9, 2015, 00:00 AM by Michael Croft
    EDINBURGH, UNITED KINGDOM - Jul 9, 2015 - Aridhia, the pioneering clinical and translational informatics company, today announced a revolutionary “mini-app” rapid development solution specifically for clinical applications
    Full story
  • Sequencing the genome creates so much data we don’t know what to do with it

    Jul 8, 2015, 00:00 AM by Michael Croft
    Washington Post | Scientists say genomics will end up being the biggest data hog, set to surpass astronomy, particle physics -- even YouTube.
    Full story
  • GlaxoSmithKline Searching For Hit Drugs Pours $95M Into DNA Dark Matter

    Jul 8, 2015, 00:00 AM by Michael Croft
    Forbes | GlaxoSmithKline is investing $95 million in a nonprofit research center in Seattle called the Altius Institute for Biomedical Sciences, focusing on the "dark matter" of the genome.
    Full story
  • HealthSeq Study Offers Healthy New Yorkers Whole Genome Sequencing

    Jul 7, 2015, 09:50 AM by Michael Croft
    Bio-IT World | Following on studies like ClinSeq and MedSeq, Mount Sinai School of Medicine's HealthSeq project is tracking patient responses to genome-wide testing, in an effort to extend these studies to a more diverse population and include non-health-related results like ancestry and physical trait information.
    Full story
  • EDGC and DIAGNOMICS SIGN AS INITIAL CUSTOMER FOR MAVERIX Dx PLATFORM

    Jul 7, 2015, 00:00 AM by Michael Croft
    SAN MATEO, CA - Jul 7, 2015 - Maverix Biomics, Inc. today announced that EDGC (the Eone-Diagnomics Genome Center), a joint venture between an affiliate of the Eone Life Science Institute and Diagnomics, signed a contract to be the initial diagnostic testing customer on the Maverix Dx Platform
    Full story
  • «
  • 361
  • 362
  • 363
  • 364 (current)
  • 365
  • 366
  • 367
  • 368
  • 369
  • 370
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy